Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.80% for the current model date.
BlackTreeCVE IntelligenceUnknown · Unknown
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
These OSV and GitHub advisory ranges apply only to the named package and ecosystem. A listed fixed version is not a universal product patch or proof that an update is installed.
| Ecosystem and package | Affected range | First fixed version | Evidence |
|---|---|---|---|
| mavencom.liferay.portal:release.dxp.bom | >= 7.3.10.fp0, < 7.3.10.fp1 | 7.3.10.fp1 | GitHub advisory ↗github reviewed aggregator · 14 May 2025 |
| mavencom.liferay.portal:release.portal.bom | >= 7.3.2, <= 7.3.5 | Not stated | GitHub advisory ↗github reviewed aggregator · 14 May 2025 |
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Fix not verifiedCross-site scripting (XSS) vulnerability in the Redirect module's redirection administration page in Liferay Portal 7.3.2 through 7.3.5, and Liferay DXP 7.3 before fix pack 1 allows remote attackers to inject arbitrary web script or HTML via the _com_liferay_redirect_web_internal_portlet_RedirectPortlet_destinationURL parameter.
Cross-site scripting (XSS) vulnerability in the Redirect module's redirection administration page in Liferay Portal 7.3.2 through 7.3.5, and Liferay DXP 7.3 before fix pack 1 allows remote attackers to inject arbitrary web script or HTML via the _com_liferay_redirect_web_internal_portlet_RedirectPortlet_destinationURL parameter.
Attacker-controlled content can reach a browser as executable script without sufficient output encoding or sanitisation.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
Cross-site scripting (XSS) vulnerability in the Redirect module's redirection administration page in Liferay Portal 7.3.2 through 7.3.5, and Liferay DXP 7.3 before fix pack 1 allows remote attackers to inject arbitrary web script or HTML via the _com_liferay_redirect_web_internal_portlet_RedirectPortlet_destinationURL parameter.
Attacker-controlled content can reach a browser as executable script without sufficient output encoding or sanitisation.
An attacker operating through a network path may attempt exploitation without authentication after a user interaction. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting'). The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 17 May 2021 · Last source change 9 Jul 2026, 00:13 UTC · CWE-79 · Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Missing structured fields: affected product. Missing data is not evidence of low risk; review the primary advisory.
No material field changes have been recorded since change tracking began. Routine source refreshes and cosmetic edits are intentionally excluded.